» Authors » Philip A Clayton

Philip A Clayton

Explore the profile of Philip A Clayton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 1092
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mulley W, Hughes P, Collins M, Pilmore H, Clayton P, Wyld M, et al.
Nephrology (Carlton) . 2024 Sep; 29(12):930-940. PMID: 39349052
Aim: Determining specific causes of allograft failure allows a focus on understanding and treating these conditions. Previous studies highlight chronic antibody-mediated rejection as a leading cause of late allograft failure....
2.
Bateman S, Owen K, Lester R, Pearson O, Lawton P, McDonald S, et al.
Med J Aust . 2024 Jun; 221(2):111-116. PMID: 38894650
Objectives: To quantify the survival benefit of kidney transplantation for Aboriginal and Torres Strait Islander people waitlisted for deceased donor kidney transplantation in Australia. Study Design: Retrospective cohort study; analysis...
3.
McMichael L, Gulyani A, Clayton P
Nephrology (Carlton) . 2023 Nov; 29(3):143-153. PMID: 38014653
Aim: Kidney transplantation remains the preferred standard of care for patients with kidney failure. Most patients do not access this treatment and wide variations exist in which patients access transplantation....
4.
Collins M, Fahim M, Pascoe E, Hawley C, Johnson D, Varghese J, et al.
Lancet . 2023 Jun; 402(10396):105-117. PMID: 37343576
Background: Delayed graft function (DGF) is a major adverse complication of deceased donor kidney transplantation. Intravenous fluids are routinely given to patients receiving a transplant to maintain intravascular volume and...
5.
Lu J, Hewawasam E, Davies C, Clayton P, McDonald S, Jesudason S
Clin J Am Soc Nephrol . 2023 Apr; 18(7):920-929. PMID: 37099453
Background: Transplanted women have high rates of preeclampsia. However, determinants of preeclampsia and association with graft survival and function remain uncertain. We aimed to determine rates of preeclampsia and its...
6.
Irish G, Cuthbertson L, Kitsos A, Saunder T, Clayton P, Jose M
Nephrology (Carlton) . 2023 Apr; 28(6):328-335. PMID: 37076122
Aims: Predicting progression to kidney failure for patients with chronic kidney disease is essential for patient and clinicians' management decisions, patient prognosis, and service planning. The Tangri et al Kidney...
7.
Irish G, Campbell S, Kanellis J, Wyburn K, Clayton P
Nephrology (Carlton) . 2023 Mar; 28(5):292-298. PMID: 36941195
Aims: The Australian estimated post-transplant survival (EPTS-AU) prediction score was developed by re-fitting the United States of America EPTS, without diabetes, to the Australian and New Zealand kidney transplant population...
8.
Irish G, McMichael L, Kadatz M, Boudville N, Campbell S, Chadban S, et al.
Am J Transplant . 2023 Feb; 23(2):232-238. PMID: 36804131
The inclusion of blood group- and human leukocyte antigen-compatible donor and recipient pairs (CPs) in kidney paired donation (KPD) programs is a novel strategy to increase living donor (LD) transplantation....
9.
Irish G, Weightman A, Hersch J, Coates P, Clayton P
Clin Transplant . 2023 Feb; 37(4):e14928. PMID: 36744626
Background: Decisions about solid organ transplantation are complex. Patient decision aids (PDAs) enhance traditional education, by improving knowledge and supporting patients to align their values with treatments. There are increasing...
10.
Weightman A, Coghlan S, Clayton P
Monash Bioeth Rev . 2022 Dec; 41(2):156-173. PMID: 36484936
Doctors routinely refuse donation offers from prospective living kidney donors with certain comorbidities such as diabetes or obesity out of concern for donor wellbeing. This refusal occurs despite the ongoing...